ClinicalTrials.Veeva

Menu
C

CIMS Hospital | Research Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Mavacamten
Macitentan
Astegolimab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

The purpose of this study is to evaluate the safety, tolerability and effectiveness of mavacamten in adults with obstructive hypertrophic cardiomyopa...

Enrolling
Symptomatic Obstructive Hypertrophic Cardiomyopathy
Drug: Mavacamten

This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COP...

Enrolling
Chronic Obstructive Pulmonary Disease (COPD)
Drug: Astegolimab
Drug: Placebo

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committe...

Active, not recruiting
Pulmonary Arterial Hypertension
Drug: Placebo
Drug: Macitentan 75 mg

Trial sponsors

Bristol-Myers Squibb (BMS) logo
Actelion Pharmaceuticals logo
Roche logo
I

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems